Percutaneous radiofrequency ablation for hepatocellular carcinoma

@article{Tateishi2005PercutaneousRA,
  title={Percutaneous radiofrequency ablation for hepatocellular carcinoma},
  author={R. Tateishi and S. Shiina and T. Teratani and S. Obi and Shin'pei Sato and Y. Koike and T. Fujishima and H. Yoshida and T. Kawabe and M. Omata},
  journal={Cancer},
  year={2005},
  volume={103}
}
Radiofrequency ablation (RFA) was introduced recently as a therapeutic modality for hepatocellular carcinoma (HCC), an alternative to percutaneous ethanol injection therapy (PEIT), which is coming into use worldwide. Previously reported treatment efficacy and complication rates have varied considerably. 
Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy
Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma
Percutaneous tumor ablation for hepatocellular carcinoma.
Percutaneous ablation of hepatocellular carcinoma: current status.
Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection
Complications of radiofrequency coagulation of liver tumours
...
1
2
3
4
5
...